UBS Maintains Neutral on Celestica, Raises Price Target to $400

Benzinga Newsdesk www.benzinga.com Positive 62.1%

Neg 0% Neu 0% Pos 62.1%

UBS analyst David Vogt maintains Celestica (NYSE:CLS) with a Neutral and raises the price target from $355 to $400.

Comments

No comments yet. Be the first!